A stromal–immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study
European Journal of Cancer · 2026-10 · 246 · 116979
DOI: 10.1016/j.ejca.2026.116979 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2026-10. Verfasst von Bolin Song und 14 weiteren Autor:innen. Beteiligte Einrichtung: Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Immune Checkpoint Inhibitors, Stromal Cells, Tertiary Lymphoid Structures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, Office of Research and Development.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.
- Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology (Southeast University), Department of Radiology, Zhongda Hospital, Medical School of Southeast University, Nanjing, Jian…
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA; Mathematics Department, Faculty of Science, Mansoura University, Mansoura, Egypt; Atlanta…
- Institute of Artificial Intelligence in Medicine, School of Artificial Intelligence in Medicine, Nanjing University of Information Science and Technology, Nanjing, Jiangsu, China.
- Department of Biological Sciences, College of Science and Mathematics, Augusta University, Augusta, GA, USA.
- Department of Pathology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Förderung
- NCI NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- Office of Research and Development
- National Institute of Biomedical Imaging and Bioengineering
- National Heart Lung and Blood Institute
- Advanced Research Projects Agency
- Scott R. MacKenzie Foundation
- Fund for Innovation in Cancer Informatics
Zitieren
APA
Song, B., Maurya, H., Xia, T., Tokuyama, N., Hammouda, K., Wang, X., Mohammad, I., Pathak, T., Zhang, X., Master, V. A., Bilen, M. A., Gupta, S., Lu, C., Wang, H., & Madabhushi, A. (2026). A stromal–immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study. European Journal of Cancer, 246, 116979. https://doi.org/10.1016/j.ejca.2026.116979
Vancouver
Song B, Maurya H, Xia T, Tokuyama N, Hammouda K, Wang X, et al. A stromal–immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study. European Journal of Cancer. 2026;246:116979. doi:10.1016/j.ejca.2026.116979
BibTeX
@article{Song2026,
author = {Song, Bolin and Maurya, Himanshu and Xia, Tianyi and Tokuyama, Naoto and Hammouda, Kamal and Wang, Xiangxue and Mohammad, Ibrahim and Pathak, Tilak and Zhang, Xiuming and Master, Viraj A and Bilen, Mehmet Asim and Gupta, Shilpa and Lu, Cheng and Wang, Hexiang and Madabhushi, Anant},
title = {A stromal–immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study},
journal = {European Journal of Cancer},
year = {2026},
volume = {246},
pages = {116979},
doi = {10.1016/j.ejca.2026.116979}
}
EUVIMED